Our understanding of the genetic risk factors underlying glaucoma has greatly increased in the past decade due to national and international research efforts. Learn about the genetic factors that can influence the early- and late-onset forms of glaucoma.
The Family Connection
Those with first-degree blood relatives who have glaucoma do indeed have an increased risk of developing this eye disease compared to the general population. The National Eye Institute encourages people with a high risk for glaucoma to have a comprehensive dilated eye exam at least once every two years. The risk group includes African Americans over age 40; everyone over age 60, especially Mexican Americans; and people with a family history of the disease. Early detection can be very beneficial in preventing vision loss due to glaucoma.
Glaucoma Genetics and Personalized Medicine
In recent years, our knowledge of the genetic risk factors for various forms of glaucoma has expanded considerably. This is exciting for several reasons.
- For some forms of early-onset glaucoma (to be discussed below), genetic testing is already available and can help with diagnosis and genetic counseling for parents-to-be.
- Although there are no gene-directed treatments or cures available currently, there are some forms of glaucoma in which our understanding of the gene mutations may one day lead to personalized treatments for those patients harboring these specific gene mutations.
- As research progresses and more genetic risk factors are identified, it may be possible to offer patients personalized glaucoma risk assessments and/or treatments.
The Gene Culprits
The genetic risk factors that underlie early-onset glaucoma (diagnosed at age 35 or earlier) have been fairly well-studied.
For example, we know that primary congenital glaucoma, a form of glaucoma diagnosed in infancy, can be caused by mutations in two genes, CYP1B1 or LTBP2. Mutations in these genes can lead to glaucoma inherited in an “autosomal recessive” fashion where both parents are carriers of the mutation but do not have glaucoma. Some of their children, however, may inherit both copies of the mutation (one from each parent), which results in the child having glaucoma.
Another type of childhood glaucoma is developmental glaucoma that is associated with mutations in genes that are involved in the development of the eye. These children often have abnormalities in the front part of the eye, and in structures that drain the eye fluid. Some of the genes associated with these different forms of developmental glaucoma include PITX2, PAX6, and FOXC1.
Mutations in these genes are inherited in an “autosomal dominant” fashion in which 50 percent of the children in the family may be affected because only one copy of the mutated gene needs to be inherited in order for the glaucoma to be apparent.
Patients who are diagnosed with glaucoma before the age of 35 may have a form of glaucoma that is associated with a mutation in a gene called myocilin. Mutations in this gene are also inherited in an autosomal dominant fashion, which means that parents with this form of early-onset glaucoma may pass the mutation onto 50 percent of their children. There are also genetic tests available to detect mutations in myocilin, so these patients should undergo genetic testing and have regular comprehensive eye examinations.
For all of these forms of glaucoma it is important for potential parents-to-be to have discussions with a genetic counselor. Furthermore, genetic testing is available for these genes and may be covered by health insurance. It is best to talk first with your ophthalmologist about genetic testing.
Age-Related Open-Angle Glaucoma
What about age-related open-angle glaucoma that affects the majority of patients who have glaucoma? It is known that this common form of glaucoma does not have just one gene mutation that causes the disease. Rather, it is likely that there are multiple gene variants that confer risk to having the disease.
Recent studies collected samples from tens of thousands of glaucoma patients and compared them to patients without glaucoma, and have identified a number of genetic variants or genes that convey some risk for open-angle glaucoma.
These include CDKN2B-AS, SIX1/SIX6, TMCO1, and CAV1/CAV2. Indeed, the CDKN2B-AS gene and a region on chromosome 8 were identified to be associated with normal-tension glaucoma, where people have glaucoma, but do not have elevated eye pressure.
The take home message is that recent research has opened up avenues to our understanding of the underlying genetics of common forms of adult-onset glaucoma. However, it is not as straightforward as a single gene mutation leading to glaucoma, so at this point there is no genetic testing recommended for the common forms of adult-onset primary open-angle glaucoma. In the future, however, there may be new genetic testing strategies that examine multiple genes.
In summary, if you have family members with glaucoma, it is recommended that you have a comprehensive dilated eye examination. If those family members with glaucoma have had surgery or have become blind, it is even more important for you to undergo routine eye examinations so that if you do have the disease, it is caught at an early stage. Finally, if you have glaucoma, let your family members know about your diagnosis so that they have a comprehensive dilated eye examination. Patients who are diagnosed with early-stage glaucoma fare much better than patients who are diagnosed at a late stage of the disease.
This content was last updated on: March 20, 2017
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.